In addition, in a mixed population of individuals that were either normal or diagnosed with NAFLD, ACBP/DBI plasma levels correlate with signs of reduced liver function, such as an increase in plasma bilirubin or a decrease in albumin levels (Table 1). This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.